Within the Dengue Fever Treatment Market , antipyretics hold the largest share, reflecting their established role in managing fever and discomfort in patients. According to the MRFR report, antipyretics are widely used and readily available, making them a first-line treatment for many patients. Their popularity stems from their accessibility and broad acceptance in managing dengue symptoms, ensuring consistent demand. This segment remains the cornerstone of symptomatic management.

While antipyretics lead, fluid replacement therapy is the fastest-growing segment. This therapy is crucial in treating the effects of dengue, especially in severe cases where dehydration and plasma leakage are major concerns. As awareness around effective management strategies grows, healthcare providers emphasize its importance in preventing complications associated with fluid loss. Oral rehydration solutions are used for milder cases, while intravenous fluids are essential for patients with severe dengue, requiring hospitalization. The increasing recognition of the importance of timely and adequate fluid resuscitation is driving the growth of this segment.

Corticosteroids and platelet transfusion represent other important treatment modalities. Corticosteroids are used to manage inflammation and immune response, while platelet transfusion is reserved for patients with severe thrombocytopenia (low platelet count) and bleeding risk. However, the use of these treatments is more selective and they hold a smaller market share compared to antipyretics and fluid replacement therapy.

The route of administration is a critical aspect of treatment delivery. Intravenous administration holds the largest share, particularly for severe cases requiring rapid hydration and medication delivery in hospital settings. Oral administration is the fastest-growing segment, appealing to patients for its convenience and ease of use, especially for milder cases managed on an outpatient basis. The rise of telemedicine and remote patient monitoring has further propelled the oral administration trend, facilitating self-management and reducing hospital visits.

The evolution of supportive care, with a growing emphasis on early and aggressive fluid management, is a key trend in the dengue treatment landscape. As healthcare providers prioritize comprehensive protocols that address both fever management and fluid balance, both antipyretics and fluid replacement therapy are expected to play essential roles, with fluid replacement therapy gaining increasing prominence.